annual CFO:
-$140.63M+$1.02B(+87.85%)Summary
- As of today (June 22, 2025), ONC annual cash flow from operations is -$140.63 million, with the most recent change of +$1.02 billion (+87.85%) on December 31, 2024.
- During the last 3 years, ONC annual CFO has risen by +$1.16 billion (+89.17%).
- ONC annual CFO is now -1202.82% below its all-time high of $12.75 million, reached on December 1, 2017.
Performance
ONC Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$44.08M-$31.08M(-41.35%)Summary
- As of today (June 22, 2025), ONC quarterly cash flow from operations is $44.08 million, with the most recent change of -$31.08 million (-41.35%) on March 1, 2025.
- Over the past year, ONC quarterly CFO has increased by +$352.65 million (+114.29%).
- ONC quarterly CFO is now -76.60% below its all-time high of $188.37 million, reached on September 30, 2024.
Performance
ONC quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$212.02M+$352.65M(+250.77%)Summary
- As of today (June 22, 2025), ONC TTM cash flow from operations is $212.02 million, with the most recent change of +$352.65 million (+250.77%) on March 1, 2025.
- Over the past year, ONC TTM CFO has increased by +$1.11 billion (+123.50%).
- ONC TTM CFO is now at all-time high.
Performance
ONC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ONC Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.8% | +114.3% | +123.5% |
| 3 y3 years | +89.2% | +118.6% | +112.8% |
| 5 y5 years | +81.3% | +112.9% | +118.7% |
ONC Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.6% | -76.6% | +107.8% | at high | +111.6% |
| 5 y | 5-year | at high | +90.6% | -76.6% | +107.8% | at high | +111.6% |
| alltime | all time | -1202.8% | +90.6% | -76.6% | +107.8% | at high | +111.6% |
ONC Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $44.08M(-41.3%) | $212.02M(-250.8%) |
| Dec 2024 | -$140.63M(-87.8%) | $75.16M(-60.1%) | -$140.63M(-67.9%) |
| Sep 2024 | - | $188.37M(-297.1%) | -$437.43M(-37.9%) |
| Jun 2024 | - | -$95.59M(-69.0%) | -$703.95M(-22.0%) |
| Mar 2024 | - | -$308.57M(+39.2%) | -$902.25M(-22.0%) |
| Dec 2023 | -$1.16B(-22.7%) | -$221.64M(+183.6%) | -$1.16B(-7.7%) |
| Sep 2023 | - | -$78.15M(-73.4%) | -$1.25B(-27.8%) |
| Jun 2023 | - | -$293.89M(-47.9%) | -$1.74B(-4.7%) |
| Mar 2023 | - | -$563.78M(+77.2%) | -$1.82B(+21.9%) |
| Dec 2022 | -$1.50B(+15.2%) | - | - |
| Dec 2022 | - | -$318.19M(-43.4%) | -$1.50B(-11.2%) |
| Sep 2022 | - | -$561.91M(+47.9%) | -$1.69B(+4.1%) |
| Jun 2022 | - | -$379.96M(+60.6%) | -$1.62B(-2.4%) |
| Mar 2022 | - | -$236.56M(-53.4%) | -$1.66B(+27.8%) |
| Dec 2021 | -$1.30B(+1.2%) | -$507.84M(+2.4%) | -$1.30B(+15.6%) |
| Sep 2021 | - | -$495.71M(+18.0%) | -$1.12B(+15.4%) |
| Jun 2021 | - | -$420.27M(-436.0%) | -$973.75M(+19.3%) |
| Mar 2021 | - | $125.09M(-137.6%) | -$816.42M(-36.4%) |
| Dec 2020 | -$1.28B(+71.1%) | -$332.33M(-4.0%) | -$1.28B(+5.3%) |
| Sep 2020 | - | -$346.24M(+31.7%) | -$1.22B(+7.1%) |
| Jun 2020 | - | -$262.94M(-23.1%) | -$1.14B(+23.6%) |
| Mar 2020 | - | -$341.94M(+28.0%) | -$920.24M(+22.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$750.27M(+37.0%) | -$267.18M(+0.8%) | -$750.27M(+10.8%) |
| Sep 2019 | - | -$265.01M(+474.9%) | -$676.98M(+24.4%) |
| Jun 2019 | - | -$46.10M(-73.2%) | -$544.15M(-11.5%) |
| Mar 2019 | - | -$171.97M(-11.3%) | -$615.19M(+12.3%) |
| Dec 2018 | -$547.72M(-4395.1%) | -$193.89M(+46.7%) | -$547.72M(+110.6%) |
| Sep 2018 | - | -$132.19M(+12.8%) | -$260.07M(+114.4%) |
| Jun 2018 | - | -$117.14M(+12.1%) | -$121.29M(+116.4%) |
| Mar 2018 | - | -$104.50M(-211.5%) | -$56.04M(-539.4%) |
| Dec 2017 | $12.75M(-114.2%) | $93.75M(+1320.4%) | $12.75M(-111.9%) |
| Sep 2017 | - | $6.60M(-112.7%) | -$107.14M(-22.4%) |
| Jun 2017 | - | -$51.89M(+45.3%) | -$138.01M(+31.0%) |
| Mar 2017 | - | -$35.71M(+36.6%) | -$105.38M(+17.7%) |
| Dec 2016 | -$89.51M(+124.7%) | -$26.14M(+7.7%) | -$89.51M(+11.7%) |
| Sep 2016 | - | -$24.28M(+26.1%) | -$80.14M(+21.9%) |
| Jun 2016 | - | -$19.26M(-2.9%) | -$65.74M(+17.4%) |
| Mar 2016 | - | -$19.84M(+18.4%) | -$55.97M(+40.5%) |
| Dec 2015 | -$39.84M(+358.3%) | -$16.76M(+69.7%) | -$39.84M(+72.6%) |
| Sep 2015 | - | -$9.88M(+4.1%) | -$23.08M(+74.8%) |
| Jun 2015 | - | -$9.49M(+155.8%) | -$13.20M(+255.8%) |
| Mar 2015 | - | -$3.71M | -$3.71M |
| Dec 2014 | -$8.69M(-313.5%) | - | - |
| Dec 2013 | $4.07M | - | - |
FAQ
- What is BeOne Medicines annual cash flow from operations?
- What is the all time high annual CFO for BeOne Medicines?
- What is BeOne Medicines annual CFO year-on-year change?
- What is BeOne Medicines quarterly cash flow from operations?
- What is the all time high quarterly CFO for BeOne Medicines?
- What is BeOne Medicines quarterly CFO year-on-year change?
- What is BeOne Medicines TTM cash flow from operations?
- What is the all time high TTM CFO for BeOne Medicines?
- What is BeOne Medicines TTM CFO year-on-year change?
What is BeOne Medicines annual cash flow from operations?
The current annual CFO of ONC is -$140.63M
What is the all time high annual CFO for BeOne Medicines?
BeOne Medicines all-time high annual cash flow from operations is $12.75M
What is BeOne Medicines annual CFO year-on-year change?
Over the past year, ONC annual cash flow from operations has changed by +$1.02B (+87.85%)
What is BeOne Medicines quarterly cash flow from operations?
The current quarterly CFO of ONC is $44.08M
What is the all time high quarterly CFO for BeOne Medicines?
BeOne Medicines all-time high quarterly cash flow from operations is $188.37M
What is BeOne Medicines quarterly CFO year-on-year change?
Over the past year, ONC quarterly cash flow from operations has changed by +$352.65M (+114.29%)
What is BeOne Medicines TTM cash flow from operations?
The current TTM CFO of ONC is $212.02M
What is the all time high TTM CFO for BeOne Medicines?
BeOne Medicines all-time high TTM cash flow from operations is $212.02M
What is BeOne Medicines TTM CFO year-on-year change?
Over the past year, ONC TTM cash flow from operations has changed by +$1.11B (+123.50%)